Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

Breast Cancer Research and Treatment

Volumn 99, Issue 3, 2006, Pages 313-321

  Hershman, Dawn L ^a,b,c,d   Wang, Xiaoyan ^b   McBride, Russell ^b   Jacobson, Judith S ^b   Grann, Victor R ^a,b,c   Neugut, Alfred I ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Breast cancer; Chemotherapy; Delay; Elderly; SEER Medicare

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE RECEPTOR;

AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; ELDERLY CARE; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICARE; PRIORITY JOURNAL; PROGNOSIS; RURAL AREA; THERAPY DELAY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; LINEAR MODELS; MEDICARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 33748346621     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9206-z     Document Type: Article

References (24)

1. Coburn NG, Chung MA, Fulton J, Cady B: Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control 11: 222-230, 2004
2. Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK: System delay in breast cancer in whites and blacks. Am J Epidemiol 142: 804-812, 1995
3. Caplan LS, Wells BL, Haynes S: Breast cancer screening among older racial/ethnic minorities and whites: barriers to early detection. J Gerontol 47 (Spec No): 101-110, 1992
4. Bickell NA, Young GJ: Coordination of care for early-stage breast cancer patients. J Gen Intern Med 16: 737-742, 2001
5. Freeman HP, Muth BJ, Kerner JF: Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 3: 19-30, 1995
6. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ: Influence of delay on survival in patients with breast cancer: a systematic review. Lancet 353: 1119-1126, 1999
7. Gwyn K, Bondy ML, Cohen DS, Lund MJ, Li. JM, Flagg EW, Brinton LA, Eley JW, Coates RJ: Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer 100: 1595-1604, 2004
8. Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, Rudenstam CM, Lindtner J, Collins J, Thurlimann B, Holmberg S, Veronesi A, Marini G, Goldhirsch A: Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol 18: 584-590, 2000
9. Shannon C, Ashley S, Smith IE: Does timing of adjuvant chemotherapy for early breast cancer influence survival? J Clin Oncol 21: 3792-3797, 2003
10. Cold S, During M, Ewertz M, Knoop A, Moller S: Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer 93: 627-632, 2005
11. Pronzato P, Campora E, Amoroso D, Bertelli G, Botto F, Conte PF, Sertoli MR, Rosso R: Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol 12: 481-485, 1989
12. Buzdar AU, Smith TL, Powell KC, Blumenschein GR, Gehan EA: Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat 2: 163-169, 1982
13. Klabunde CN, Warren JL, Legler JM: Assessing comorbidity using claims data: an overview. Med Care 40: IV-26-IV35, 2002
14. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40: IV-55-IV61, 2002
15. Bach PB, Cramer LD, Warren JL, Begg CB: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341: 1198-1205, 1999
16. Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr.: Assessing illness severity: does clinical judgment work? J Chronic Dis 39: 439-452, 1986
17. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619, 1992
18. Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53: 1258-1267, 2000
19. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21: 555-563, 2003
20. Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK: Reasons for delay in breast cancer diagnosis. Prev Med 25: 218-224, 1996
21. Shavers VL, Harlan LC, Stevens JL: Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97: 134-147, 2003
22. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M: Trends in breast cancer by race and ethnicity. CA Cancer J Clin 53: 342-355, 2003
23. Vercelli M, Lillini R, Capocaccia R, Micheli A, Coebergh JW, Quinn M, Martinez-Garcia C, Quaglia A: Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project). Eur J Cancer 42: 234-242, 2006
24. Neal RD, Allgar VL: Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the "National Survey of NHS Patients: Cancer". Br J Cancer 92: 1971-1975, 2005